Best Practice & Research Clinical Rheumatology
Volume 23, Issue 1 , Pages 117-123 , February 2009

The use of data from early arthritis clinics for clinical research

  • Daniel Aletaha, MD, MS (Associate Professor)

      Affiliations

    • Division of Rheumatology, Department of Internal Medicine 3, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 1 40400 4301.
    • ,
  • T.W.J. Huizinga, MD, PhD (Professor)

      Affiliations

    • Department of Rheumatology, C1-41, Leiden University Medical Centre, Albinusdreef 2, PO Box 9600, 2300RC Leiden, The Netherlands

References 

  1. Wolfe F. The natural history of rheumatoid arthritis. J Rheumatol. 1996;44(Suppl.):13–22
  2. Pincus T, Callahan LF, Sale WG, et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum. 1984;27:864–872
  3. Smolen JS, Aletaha D. Patients with rheumatoid arthritis in clinical care. Ann Rheum Dis. 2004;63(3):221–225
  4. Wilske KR, Healey LA. Challenging the therapeutic pyramid: a new look at treatment strategies for rheumatoid arthritis. J Rheumatol. 1990;17(Suppl. 25):4–7
  5. Fries JF, Williams CA, Ramey D, Bloch DA. The relative toxicity of disease-modifying antirheumatic drugs. Arthritis Rheum. 1993;36(3):297–306
  6. Fries JF, Williams CA, Bloch DA. The relative toxicity of nonsteroidal antiinflammatory drugs. Arthritis Rheum. 1991;34(11):1353–1360
  7. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–324
  8. Silman AJ, Symmons DP. Selection of study population in the development of rheumatic disease criteria: comment on the article by the American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1995;38(5):722–723
  9. van Aken J, van Bilsen JH, Allaart CF, et al. The Leiden Early Arthritis Clinic. Clin Exp Rheumatol. 2003 Sep–Oct;21(5 Suppl. 31):S100–S105Review
  10. Nielen MM, van Schaardenburg , Reesink WH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50:380–386
  11. Emery P, Breedveld FC, Dougados M, et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis. 2002;61(4):290–297
  12. van Dongen H, van Aken J, Lard LR, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2007 May;56(5):1424–1432
  13. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med. 2007 Mar 20;146(6):406–415
  14. van der Helm-van Mil AH, le CS, van DH, et al. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum. 2007;56(2):433–440
  15. Green M, Marzo-Ortega H, McGonagle D, et al. Persistence of mild, early inflammatory arthritis: the importance of disease duration, rheumatoid factor, and the shared epitope. Arthritis Rheum. 1999;42(10):2184–2188
  16. Harrison BJ, Symmons DP, Brennan P, et al. Inflammatory polyarthritis in the community is not a benign disease: predicting functional disability one year after presentation. J Rheumatol. 1996;23(8):1326–1331
  17. Bukhari M, Lunt M, Harrison BJ, et al. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum. 2002;46(4):906–912
  18. Visser H, le Cessie S, Vos K, et al. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum. 2002;46(2):357–365
  19. van der Helm-van Mil AH, Detert J, le CS, et al. Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making. Arthritis Rheum. 2008;58(8):2241–2247
  20. Aletaha D, Breedveld FC, Smolen JS. The need for new classification criteria for rheumatoid arthritis. Arthritis Rheum. 2005;52(11):3333–3336
  21. Aletaha D, Eberl G, Nell VP, et al. Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey. Ann Rheum Dis. 2004;63(10):1269–1275
  22. Symmons DP, Bankhead CR, Harrison BJ, et al. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum. 1997;40(11):1955–1961
  23. Heliovaara M, Aho K, Aromaa A, et al. Smoking and risk of rheumatoid arthritis. J Rheumatol. 1993;20(11):1830–1835
  24. Uhlig T, Hagen KB, Kvien TK. Current tobacco smoking, formal education, and the risk of rheumatoid arthritis. J Rheumatol. 1999;26(1):47–54
  25. Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis. 2006 Mar;65(3):366–371Epub 2005 Jul 13
  26. Kallberg H, Padyukov L, Plenge RM, et al. Epidemiological Investigation of Rheumatoid Arthritis study group.Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet. 2007 May;80(5):867–875
  27. van der Helm-van Mil AH, Huizinga TW. Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res Ther. 2008;10(2):205
  28. van Oosterhout M, Bajema I, Levarht EW, et al. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum. 2008 Jan;58(1):53–60
  29. van Gaalen FA, van Aken J, Huizinga TW, et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum. 2004 Jul;50(7):2113–2121

PII: S1521-6942(08)00150-2

doi: 10.1016/j.berh.2008.11.008

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 1 , Pages 117-123 , February 2009

Article Tools

* Image Usage & Resolution